Mayor Touts Ebola, HIV Advances at The Scripps Research Institute
Faulconer, EDC Boast Opportunities and Innovation Economy in San Diego
Friday, October 31, 2014 - NEWS RELEASE
San Diego, CA – With more than 80 research institutes throughout the region, San Diego is a breeding ground for innovative companies and organizations that solve some of the world’s toughest challenges. Following news that the experimental San Diego-manufactured drug ZMapp was used in an effort to help selected Ebola patients, Mayor Kevin L. Faulconer joined the San Diego Regional EDC to highlight local innovative solutions to global issues such as Ebola at The Scripps Research Institute (TSRI).
As part of his commitment to raising global awareness of the region’s innovation economy, Mayor Faulconer has partnered with the EDC to tour some of San Diego’s most cutting-edge businesses and institutes, including TSRI. Currently, TSRI Professor Erica Ollmann Saphire is advancing new Ebola therapies and has already contributed to the development of ZMapp, the Ebola therapy given to the first two U.S. missionaries who survived infection. TSRI Professor Dennis Burton and his colleagues are also taking a global leadership role in the development of a vaccine to combat HIV/AIDS, focusing on understanding rare antibodies that are effective in neutralizing the virus.
CONTACT: Charles Chamberlayne at (619) 453-9911 or email@example.com